Tokai Pharmaceuticals' Series D - III Round

Tokai Pharmaceuticals raised a round of funding on September 20, 2011.

Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug…

Articles about Tokai Pharmaceuticals' Series D - III Round: